A detailed history of Central Trust CO transactions in West Pharmaceutical Services Inc stock. As of the latest transaction made, Central Trust CO holds 28 shares of WST stock, worth $9,330. This represents 0.0% of its overall portfolio holdings.

Number of Shares
28
Previous 30 6.67%
Holding current value
$9,330
Previous $9,000 11.11%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 22, 2024

SELL
$277.16 - $333.3 $554 - $666
-2 Reduced 6.67%
28 $8,000
Q2 2024

Aug 05, 2024

SELL
$314.68 - $395.94 $19,195 - $24,152
-61 Reduced 67.03%
30 $9,000
Q1 2024

Apr 24, 2024

SELL
$338.27 - $413.0 $24,355 - $29,736
-72 Reduced 44.17%
91 $36,000
Q3 2023

Oct 26, 2023

SELL
$354.9 - $412.41 $16,325 - $18,970
-46 Reduced 22.01%
163 $61,000
Q2 2023

Jul 26, 2023

BUY
$334.63 - $382.47 $34,466 - $39,394
103 Added 97.17%
209 $79,000
Q1 2023

Apr 19, 2023

SELL
$232.5 - $346.47 $15,810 - $23,559
-68 Reduced 39.08%
106 $36,000
Q4 2022

Jan 26, 2023

SELL
$209.34 - $261.61 $172,914 - $216,089
-826 Reduced 82.6%
174 $0
Q3 2022

Nov 17, 2022

SELL
$246.08 - $343.65 $117,380 - $163,921
-477 Reduced 32.3%
1,000 $246,000
Q2 2022

Aug 09, 2022

SELL
$280.61 - $420.45 $282,574 - $423,393
-1,007 Reduced 40.54%
1,477 $447,000
Q1 2022

May 03, 2022

SELL
$357.49 - $445.92 $54,338 - $67,779
-152 Reduced 5.77%
2,484 $1.02 Million
Q4 2021

Feb 08, 2022

BUY
$402.25 - $471.34 $213,594 - $250,281
531 Added 25.23%
2,636 $1.24 Million
Q3 2021

Oct 19, 2021

BUY
$363.01 - $468.47 $20,328 - $26,234
56 Added 2.73%
2,105 $893,000
Q2 2021

Jul 23, 2021

BUY
$284.77 - $363.2 $482,400 - $615,260
1,694 Added 477.18%
2,049 $735,000
Q1 2021

Apr 23, 2021

BUY
$257.29 - $307.53 $91,337 - $109,173
355 New
355 $100,000

Others Institutions Holding WST

About WEST PHARMACEUTICAL SERVICES INC


  • Ticker WST
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 74,033,000
  • Market Cap $24.7B
  • Description
  • West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers sto...
More about WST
Track This Portfolio

Track Central Trust CO Portfolio

Follow Central Trust CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Central Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Central Trust CO with notifications on news.